arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

SeaStar Medical Holding Corp

ICU

$3.27 ▲ +0.22 (+7.21%) at close

6 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

SeaStar Medical Holding Corp faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $6.8M

Dividend Yield —

Revenue Growth 814.1%

Op. Margin —

ROIC -116.9% ↘

FCF / Share $-6.56 ↘

Trailing P/E —

Price / Book 1.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.23M

↑ +814.1% —

Net Income Profit after all expenses

$-12.15M

↑ +51.1% —

FCF / Share Free cash flow per share

$-6.56

↓ -53.4% —

Long-Term Debt Long-term obligations

$4.14M

↓ -45.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	814.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+10076%)	—	—	—	—	—
EPS Growth YoY (%)	11.6% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	78.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	18.2% Good Good Year-over-year change in earnings per share Optimal: > 10%	-134.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	51.1% Excellent ↑ Excellent Improving Year-over-year change in net income	5.3% Fair ↑ Fair Improving Year-over-year change in net income	-115.2% Weak Weak Year-over-year change in net income	-165.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-53.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	64.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	50.0% Excellent Excellent Year-over-year change in free cash flow	-34.4% Weak Weak Year-over-year change in free cash flow	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Effective Tax Rate (%) (%)	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
FCF / Net Income (x)	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	-116.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	817.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	146.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	88.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	158.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-86.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-383.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-404.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-382.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-737.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-116.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-878%)	—	189.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1161%)	58.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+291%)	163.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+988%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Debt to Equity (x)	—	—	-0.30x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-150%)	-0.37x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-161%)	—	—
Interest Coverage (x)	—	-73.12x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.15x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-18.43x Weak Weak Operating income divided by interest expense Optimal: > 5x	-20.99x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	—	—	$4.14M	$7.65M	—	$-38.39K
Debt / EBITDA (x)	—	—	-0.29x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.66x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$0.60	$0.04	$0.00	—	—	—
Basic EPS, GAAP (USD)	$-5.86	$-6.63	$-30.26	$-37.00	$-15.75	—
Free Cash Flow per Share (USD)	$-6.56	$-4.28	$-11.87	$-23.73	$-17.66	—
Book Value per Share (USD)	$2.71	$-0.37	$-6.88	$-40.87	$-9.73	—
Tangible Book Value per Share (USD)	$2.71	$-0.37	$-6.88	$-40.87	$-9.73	—
Basic Weighted Avg Shares (shares)	2.07M	3.74M	866,813	328,450	289,551	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$9.84M	$-3.08M	$-10.74M	$-14.63M	$-2.52M	—
LT Debt (USD)	—	—	$4.14M	$7.65M	—	—
Total Equity (USD)	$10.42M	$-2.18M	$-13.87M	$-20.76M	$-2.82M	$19.76K

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$1.23M	$135.00K	$0.00	—	—	—
Net Income, GAAP (USD)	$-12.15M	$-24.83M	$-26.23M	$-12.19M	$-4.60M	—
Operating Cash Flow (USD)	$-13.60M	$-16.01M	$-10.29M	$-7.79M	$-5.11M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters

SeaStar Medical Holding Corp

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ICU with peers